🔎 Trials Near Me

Hjem › Pankreaskreft › Ohio

Kliniske studier for Pankreaskreft i Ohio

45 studier for Pankreaskreft søker deltakere på steder i Ohio.

Byer i Ohio

Offisiell studietekst (engelsk)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Louis Stokes Cleveland VA Medical Center, Cleveland
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 45 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06995898

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • University of Cincinnati Cancer Center, Cincinnati
  • Taylor Cancer Research Center, Maumee
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05372614

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University Hospitals Cleveland Medical Center, Cleveland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069

DESTINY-PANTUMOUR04

  • Research Site, Canton
  • Research Site, Maumee
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • The Ohio State University Comprehensive Cancer Center, Columbus
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04981119

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • Taylor Cancer Research Center, Maumee
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US050, Cleveland
  • Investigative Site US020, Cleveland
  • Investigative Site US033, Columbus
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • Facilities Design and Construction - Energy Advancement and Innovation Center, Columbus
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07409272

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain

  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07117032

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • University of Cincinnati Medical Center, Cincinnati
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06445062

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

  • University Hospital Cleveland Medical Center, Cleveland
Rekrutterer
Alder 21 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07824583

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06263088

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT05720338

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
RekruttererObservasjonsstudie
Opp til 17 år · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06651580

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

  • UH Cleveland Medical Center, Cleveland
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT05764720

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • Ohio State University Comprehensive Cancer Center, Columbus
RekruttererObservasjonsstudie
Alder 50 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT04239573

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • The Ohio State University (OSU) Wexner Medical Center, Columbus
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06400472

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Aultman Health Foundation, Canton
  • Miami Valley Hospital South, Centerville
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • og 11 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT06958328

Pancreatic Cancer Early Detection Consortium

  • The Ohio State University, Columbus
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 90 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT04970056

Integrated Cancer Repository for Cancer Research

  • Aultman Alliance Community Hospital, Alliance
  • Aultman Hospital, Canton
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

  • Ohio State University Comprehensive Cancer Center, Columbus
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jun. 2026 · NCT03711890

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • The Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT06051695

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

  • Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jun. 2026 · NCT04890613

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • The Christ Hospital, Cincinnati
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT06040541

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

  • Miami Valley Hospital South, Centerville
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • og 10 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT06998940

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Christ Hospital Cancer Center, Cincinnati
  • Taylor Cancer Research Center, Maumee
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. mai 2026 · NCT05379985

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

  • Ohio State University Comprehensive Cancer Center, Columbus
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 23. mar. 2026 · NCT05961982

Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response

  • The Ohio State University, Columbus
Rekrutterer
Alder 19 og eldre · Alle kjønn · Oppdatert 27. feb. 2026 · NCT04588025

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

  • Taylor Cancer Center, Maumee
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. feb. 2026 · NCT07049055

A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer

  • Ohio State University Comprehensive Cancer Center, Columbus
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 19. feb. 2026 · NCT07124611

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  • Cleveland Clinic, Cleveland
  • Taylor Cancer Research Center, Maumee
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. feb. 2026 · NCT07030257

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University-Telemedicine, Cincinnati
  • Ohio State University-Telemedicine, Cleveland
  • Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT06906562

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Cleveland Clinic, Cleveland
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

  • Cleveland Clinic Foundation, Cleveland
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jan. 2026 · NCT06973564

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • Strecker Cancer Center-Belpre, Belpre
  • Marietta Memorial Hospital, Marietta
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 9. jan. 2026 · NCT06073431

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Taylor Cancer Research Center (site 204), Maumee
RekruttererFase 1/2
Alder 18 til 80 · Alle kjønn · Oppdatert 11. des. 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Cincinnati
  • Massive Bio SYNERGY-AI site, Columbus
  • Massive Bio SYNERGY-AI site, Mayfield Heights
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

The Cancer of the Pancreas Screening-5 CAPS5)Study

  • Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. okt. 2025 · NCT02000089

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.